Layla Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path
Layla scores highest on the strength of its clinical program — drug options and dosing support.
Semaglutide
then $237/mo ongoing
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide and a brand-inclusive GLP-1 program covering Wegovy, Ozempic, Zepbound, and Mounjaro. Care starts with a short online quiz and a licensed-provider visit, with medication shipped in three to five days and 24-7 doctor messaging. Oral semaglutide is 237 dollars per month (187 dollars first month), and the brand program starts around 1,299 dollars. Compounded meds are not FDA-approved. Dr. Ruth Cohen is Medical Director.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Layla
Editorial score · methodology
Editorial score · methodology
Sprout Health
Best for: LegitScript-verified compounded GLP-1 via named pharmacies
Editorial score · methodology
Layla at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $187/mo (Oral dropper drops; 187 dollars first month, 237 dollars per month thereafter)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Layla
Each dimension is scored algorithmically from Layla’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.8/10At $199/mo, Layla runs about 18% above the $169 median for GLP-1 providers, and the first month drops to $187. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.1/10Layla offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. FDA-approved brand options are available alongside compounded versions. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.4/10Online intake and platform experience — ongoing clinician messaging, consult included in the price; 6 platform features disclosed.
Trust & Safety15%
6.9/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-08-02).
Accessibility10%
5.7/10Layla's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
6.0/10Clinician messaging between visits.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Layla review
Last checked August 2026- Confirmed current pricing across 3 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Layla
We walked Layla’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Take a free ~3-minute online questionnaire.
- 2A licensed provider reviews your history to determine if treatment is appropriate.
- 3If approved, medication ships in ~3-5 days in discreet packaging.
- 4Cancel anytime; subscriptions require 30-day notice.
- All-inclusive compounded pricing is public: compounded semaglutide from $99/month intro (about $297 on the monthly plan) and compounded tirzepatide from $199/month intro (about $449 monthly).
- A brand-inclusive GLP-1 program (Ozempic/Wegovy/Zepbound/Mounjaro) is advertised starting at $1,299.
- Pricing is stated to include prescription, medication, shipping, telehealth visits and messaging, with no membership fee.
- Cancellation: once an eRx is sent to the pharmacy a $100 nonrefundable visit/clinical fee applies; subscriptions need 30-day notice.
- No insurance is required; states served and lab requirements are not disclosed publicly.
- Compounded GLP-1s are the same active ingredient as the referenced brands but are not the brand products.
Layla customer support
- Phone
- 0207 427 6085
- hello@joinlayla.com
GLP-1 medications Layla offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Oral dropper drops; 187 dollars first month, 237 dollars per month thereafter
Starting first-month price for compounded tirzepatide
Brand-inclusive GLP-1 program (Wegovy/Ozempic) starting price
Ready to get started?
Plans and promotions change often — check Layla's current pricing and active discounts before you decide.
What we like
- Oral semaglutide dropper option plus injectable semaglutide and tirzepatide, with a brand-name upgrade path
- Named Medical Director (Dr. Ruth Cohen) and 24-7 doctor messaging
- Quiz-based intake with fast three to five day shipping
Watch-outs
- Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
- States served are not published on the site
- Support phone line uses a UK format, and the compounding pharmacy is not named
Is Layla worth it? Our verdict
Layla positions itself around one thing: oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path. New patients start at $187/month for the first month, but the price settles at $199/month after that — so the headline is an intro offer, not the standing rate. Its standout is a needle-free oral option, which very few providers offer.
What gives Layla its own flavor: 24/7 doctor messaging.
How much Layla actually costs
- Compounded semaglutide — $187 first month, then $237/month
- Compounded tirzepatide — $199/month
- Brand-name semaglutide — $1299/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so Layla's standing rate sits at the premium end. The first-month discount is a great way to start cheaply, but price out the ongoing rate against a flat-rate provider before you commit long term.
For a direct comparison, Eden runs semaglutide and tirzepatide from $198/month — worth pricing against Layla before you commit.
Medications: what Layla prescribes
Layla prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. Both routes are on the table: FDA-approved brand pens, or the cheaper compounded version that keeps the monthly cost down but isn't FDA-approved as a finished product.
Layla's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used, so treat it as a convenience option rather than a proven equal to the shot.
Who Layla is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
- are needle-averse and want a non-injectable option.
- value being able to message a clinician between visits.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like Sunlight will likely beat the ongoing price.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Layla offers clinician messaging between visits. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Layla is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $187 intro price steps up to $199/month once the first month is behind you. Use that window to confirm the medication works for you, then re-check the ongoing math before you settle in. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Layla scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with Layla?
Starting at $199/month. See current pricing and start your free consultation.
Layla might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Layla review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Layla's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.